3,4-Dihydroxystyrene
Clinical data | |
---|---|
ATC code | none |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | 6053-02-7 |
PubChem (CID) | 151398 |
ChemSpider | 133430 |
UNII | 28C0I29E70 |
KEGG | C06224 |
Chemical and physical data | |
Formula | C8H8O2 |
Molar mass | 136.15 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
3,4-Dihydroxystyrene (DHS) is a centrally-acting inhibitor of the enzyme phenylalanine hydroxylase (PH).[1] It is likely that DHS and other PH inhibitors will never have clinical applications on account of their capacity for inducing hyperphenylalaninemia and phenylketonuria.
See also
References
- ↑ Koizumi S; Matsushima Y; Nagatsu T; Iinuma H; Takeuchi T; Umezawa H (September 1984). "3,4-dihydroxystyrene, a novel microbial inhibitor for phenylalanine hydroxylase and other pteridine-dependent monooxygenases". Biochimica et Biophysica Acta. 789 (2): 111–8. doi:10.1016/0167-4838(84)90194-8. PMID 6148105.
This article is issued from Wikipedia - version of the 9/11/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.